NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Free Report) had its price objective lifted by National Bankshares from C$5.50 to C$5.75 in a report published on Tuesday morning,BayStreet.CA reports. National Bankshares currently has an outperform rating on the stock.
Separately, BMO Capital Markets cut their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.25 in a report on Tuesday, November 19th.
Read Our Latest Analysis on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Trading Down 0.8 %
Shares of NorthWest Health Prop Real Est Inv Trust stock traded down C$0.04 on Tuesday, hitting C$4.90. The stock had a trading volume of 855,736 shares, compared to its average volume of 650,578. The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42. NorthWest Health Prop Real Est Inv Trust has a one year low of C$4.22 and a one year high of C$5.88. The stock has a market cap of C$1.21 billion, a price-to-earnings ratio of -3.08, a PEG ratio of 0.74 and a beta of 1.05. The stock's 50-day simple moving average is C$4.71 and its two-hundred day simple moving average is C$4.95.
About NorthWest Health Prop Real Est Inv Trust
(
Get Free Report)
NorthWest Healthcare Properties Real Estate Investment Trust TSX: NWH.UN (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Featured Stories
Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.
While NorthWest Health Prop Real Est Inv Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.